enfortumab vedotin
seagen,astellas
['vedo', 'unite study', 'brca', ' vedo', '#unite', 'urothelial', 'urothelial carcinoma', 'enfortumab', '#gu,(-#gui),(-#gunagratinib),(-#guard),(-#gut)', 'biomarker', 'bladder', 'marker ']
biomarkers of response to enfortumab vedotin in patients with advanced urothelial carcinoma: analysis of the #unite study. presented by . #gu23 written coverage by &gt; 
Largest global online community of #urological medical professionals & patients. #bladdercancer #menshealth #prostatecancer #kidneycancer #Urology